Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans

Infection and Immunity

Volumn 69, Issue 12, 2001, Pages 7481-7486

  Johansson, E L ^a   Wassen L ^a   Holmgren, J ^a   Jertborn, M ^a   Rudin, A ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; ELDEXOMER; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX; VACCINATION; VAGINA SECRETION;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, INTRAVAGINAL; ADULT; ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; BODILY SECRETIONS; CERVIX UTERI; CHOLERA TOXIN; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MIDDLE AGED; MUCOUS MEMBRANE; VAGINA;

EID: 0035178074     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.12.7481-7486.2001     Document Type: Article

References (30)

1. Chlamydia trachomatis infection: Incidence, health costs and prospects for vaccine development
2. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory, tract and the vagina
3. Glandular distribution of immunoglobulins, J chain, secretory component, and HLA-DR in the human endometrium throughout the menstrual cycle
4. Vaginal mucosa serves as an inductive site for tolerance
5. Normal uterine cervix: Characterization of isolated lymphocyte phenotypes and immunoglobulin secretion
6. Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination
7. Actions of cholera toxin and the prevention and treatment of cholera
8. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization
9. Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers
10. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease
11. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates
12. Distribution of lymphocytes and adhesion molecules in human cervix and vagina
13. Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis
14. Differential regulation of CD4 lymphocyte recruitment between the upper and lower regions of the genital tract during Chlamydia trachomatis infection
15. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women
16. Hormonal control of the secretory immune system of the human uterine cervix
17. Antigen recognition in the female reproductive tract. II. Endocytosis of horseradish peroxidase by Langerhans cells in murine vaginal epithelium
18. Antigen recognition in the female reproductive tract. I. Uptake of intraluminal protein tracers in the mouse vagina
19. Distinct homing pathways direct T lymphocytes to the genital and intestinal mucosae in chlamydia-infected mice
20. Induction of compartmentalized B-cell responses in human tonsils
21. Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans
22. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit
23. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development
24. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine
25. A tissue-specific endothelial cell molecule involved in lymphocyte homing
26. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine
27. Intestinal antibody responses after immunisation with cholera B subunit
28. Delivery systems and adjuvants for vaccination against HIV
29. Local intravaginal vaccination of the female genital tract
30. Antigen-presenting cells in the female reproductive tract: Influence of the estrous cycle on antigen presentation by uterine epithelial and stromal cells